• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An evidence-based systematic review on medical therapies for inflammatory bowel disease.

作者信息

Talley Nicholas J, Abreu Maria T, Achkar Jean-Paul, Bernstein Charles N, Dubinsky Marla C, Hanauer Stephen B, Kane Sunanda V, Sandborn William J, Ullman Thomas A, Moayyedi Paul

机构信息

Department of Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia.

出版信息

Am J Gastroenterol. 2011 Apr;106 Suppl 1:S2-25; quiz S26. doi: 10.1038/ajg.2011.58.

DOI:10.1038/ajg.2011.58
PMID:21472012
Abstract
摘要

相似文献

1
An evidence-based systematic review on medical therapies for inflammatory bowel disease.关于炎症性肠病医学治疗的循证系统评价。
Am J Gastroenterol. 2011 Apr;106 Suppl 1:S2-25; quiz S26. doi: 10.1038/ajg.2011.58.
2
Drugs for inflammatory bowel disease.治疗炎症性肠病的药物。
Treat Guidel Med Lett. 2009 Sep;7(85):65-74; quiz 75-6.
3
[Therapy of chronic inflammatory bowel diseases].[慢性炎症性肠病的治疗]
Praxis (Bern 1994). 2002 Nov 20;91(47):2029-39. doi: 10.1024/0369-8394.91.47.2029.
4
[Chronic inflammatory bowel diseases. Update on evidence-based therapy].[慢性炎症性肠病。循证治疗的最新进展]
MMW Fortschr Med. 2005 Apr 28;147(17):58-9.
5
Methotrexate for inflammatory bowel disease: time for reconsideration.甲氨蝶呤用于炎症性肠病：是时候重新考虑了。
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):407-409. doi: 10.1080/17474124.2019.1596797. Epub 2019 Mar 21.
6
Drug development for ulcerative proctitis: current concepts.溃疡性直肠炎的药物研发：当前概念
Gut. 2021 Jul;70(7):1203-1209. doi: 10.1136/gutjnl-2021-324108. Epub 2021 Mar 31.
7
[Inflammatory bowel disease].[炎症性肠病]
Praxis (Bern 1994). 2013 Aug 21;102(17):1046-52. doi: 10.1024/1661-8157/a001380.
8
[Current medical treatment of inflammatory bowel disease].[炎症性肠病的当前医学治疗]
Rev Gastroenterol Mex. 2007 Nov;72 Suppl 2:92-101.
9
[Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].[慢性炎症性肠病免疫抑制治疗的适应证]
Internist (Berl). 1997 Jun;38(6):582-9. doi: 10.1007/s001080050070.
10
[Pharmacologic therapy of Crohn's disease and ulcerative colitis].[克罗恩病和溃疡性结肠炎的药物治疗]
Orv Hetil. 2000 May 28;141(22):1171-7.

引用本文的文献

1
Probiotic acoustic biosensors for noninvasive imaging of gut inflammation.用于肠道炎症无创成像的益生菌声学生物传感器。
Nat Commun. 2025 Aug 25;16(1):7931. doi: 10.1038/s41467-025-62569-1.
2
Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise.使用安慰剂测序和培养富集宏基因组学从噪声中筛选信号，以检测粪菌移植后的微生物植入情况。
Nat Commun. 2025 Apr 11;16(1):3469. doi: 10.1038/s41467-025-58673-x.
3
Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats.
低剂量乳果糖对葡聚糖硫酸钠诱导的大鼠溃疡性结肠炎模型的保护作用。
Sci Rep. 2025 Jan 22;15(1):2760. doi: 10.1038/s41598-025-86823-0.
4
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023.台湾溃疡性结肠炎的管理：2023年更新的台湾炎症性肠病学会共识指南
Intest Res. 2024 Jul;22(3):213-249. doi: 10.5217/ir.2023.00050. Epub 2024 Jul 29.
5
Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease.用于治疗炎症性肠病的药用植物和蠕虫的药物潜力。
Pharmaceuticals (Basel). 2024 Jun 21;17(7):819. doi: 10.3390/ph17070819.
6
Therapeutic Potential of Essential Oils Against Ulcerative Colitis: A Review.精油对溃疡性结肠炎的治疗潜力：综述
J Inflamm Res. 2024 May 31;17:3527-3549. doi: 10.2147/JIR.S461466. eCollection 2024.
7
Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer.布地奈德作为癌症患者免疫检查点抑制剂相关结肠炎治疗选择的疗效
Cancers (Basel). 2024 May 18;16(10):1919. doi: 10.3390/cancers16101919.
8
Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review.提高炎症性肠病（IBD）患者的药物依从性：一项基于证据的叙述性综述。
Patient Prefer Adherence. 2024 Apr 20;18:905-916. doi: 10.2147/PPA.S383304. eCollection 2024.
9
Rauwolfia polysaccharide can inhibit the progress of ulcerative colitis through NOS2-mediated JAK2/STAT3 pathway.萝芙木多糖可通过 NOS2 介导的 JAK2/STAT3 通路抑制溃疡性结肠炎的进展。
PLoS One. 2024 Apr 16;19(4):e0301660. doi: 10.1371/journal.pone.0301660. eCollection 2024.
10
An Atypical Case of Yersinia enterocolitica Infection in a Patient Suspected With Ulcerative Colitis Flare-Up.一例疑似溃疡性结肠炎发作患者的小肠结肠炎耶尔森菌感染非典型病例。
Cureus. 2024 Feb 7;16(2):e53780. doi: 10.7759/cureus.53780. eCollection 2024 Feb.